Davis Capital Management
WST icon

Davis Capital Management’s West Pharmaceutical WST Stock Holding History

Davis Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$371 Sell
1
-1
-50% -$353 ﹤0.01% 697
2026
Q2 		$718 Buy
2
+1
+100% +$306 ﹤0.01% 546
2026
Q1 		$251 Hold
1
– – ﹤0.01% 519
2025
Q4 		$275 Hold
1
– – ﹤0.01% 506
2025
Q3 		$262 Buy
+1
New +$243 ﹤0.01% 526

Other funds holding WST

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
Local Pensions Partnership Investment
Local Pensions Partnership Investment London, United Kingdom $4.77B AUM 16.58% 1-Year Est. Return
Seilern Investment Management
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
North Growth Management
North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return

Davis Capital Management's WST Position: Q3 2026 in Review

Davis Capital Management reduced its West Pharmaceutical (WST) stake by 50% in Q3 2026, selling an estimated $353 and leaving 1 share worth $371. The position accounts for ﹤0.01% of the portfolio, ranked #697.

Davis Capital Management first reported a position in WST in Q3 2025 and has held it in 5 quarters since. The position peaked at $718 in Q2 2026. 254 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Davis Capital Management held 1 share of West Pharmaceutical worth $371 as of Q3 2026.
  • Davis Capital Management sold 1 West Pharmaceutical share in Q3 2026, an estimated $353.
  • West Pharmaceutical made up ﹤0.01% of Davis Capital Management's portfolio in Q3 2026, its #697 holding.
  • Davis Capital Management first reported a position in West Pharmaceutical in Q3 2025 and has held it in 5 quarters since.
  • Davis Capital Management's West Pharmaceutical position peaked at $718 in Q2 2026.
  • 254 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.